Scientific evidence concerning the subacute and long-term effects of coronavirus disease 2019 (COVID-19) is on the rise. It has been established that infection by serious acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a systemic process that involves multiple organs. The complications and long-term consequences of COVID-19 are diverse and patients need a multidisciplinary treatment approach in the acute and post-acute stages of the disease. A significant proportion of COVID-19 patients experience neurological manifestations, some enduring for several months post-recovery. However, brain and skeletal muscle changes resultant from SARS CoV-2 infection remain largely unknown. Here, we provide a brief overview of the current knowledge, and usefulness, of [ 18 F]fluorodeoxyglucose positron emission tomography/computed tomography ( 18 F-FDG-PET/CT) to investigate brain and skeletal muscles changes in Post-COVID-19 patients with persistent symptoms. Furthermore, a brief discussion of future 18 F-FDG-PET/CT applications that might advance the current knowledge of the pathogenesis of post-COVID-19 is also provided.
【저자키워드】 Brain, Post-COVID, pet, muscle, glucose uptake, hypometabolism, 【초록키워드】 COVID-19, SARS CoV-2, Treatment, coronavirus disease, SARS-CoV-2, coronavirus, Pathogenesis, knowledge, Infection, tomography, Symptoms, Patient, Complication, neurological manifestations, change, COVID-19 patient, Skeletal muscle, acute respiratory syndrome, Stage, multiple organs, scientific evidence, Effect, approach, consequence, proportion, the disease, provided, changes in, concerning, 【제목키워드】 imaging, alteration,